Envoy Medical, Inc.

Envoy Medical, Inc. (Nasdaq: COCH) is a medical device company specializing in fully implantable hearing technology, including its Acclaim Cochlear Implant system. The company reached the public markets through its merger with Anzu Special Acquisition Corp I, a blank-check vehicle sponsored by Anzu Partners, which completed its SPAC IPO in 2021. The de-SPAC transaction closed in 2023, listing Envoy Medical on Nasdaq under the ticker COCH and placing it within the medical device and hearing health sector. The company filed an 8-K with the SEC on May 18, 2026, accession number 0001213900-26-058429. For complete filing history, sponsor data, and SPAC analytics on COCH, sign up for full access on SpacDesk.